Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Research Applications Maximum GH pulse amplitude studies: When peak somatotroph stimulation is the primary endpoint, GHRP-2 delivers values the other two cant match IGF-1 axis research: Robust and sustained GH elevation drives sustained IGF-1 upregulation useful in models tracing the complete GHIGF-1tissue signaling cascade Metabolic models: Body composition, adipose tissue lipolysis, and insulin sensitivity studies in diet-induced obesity where HPA co-activation is either controlled for or informative GHSR-1a pharmacology: Receptor characterization in knockout or mutant models where potent full-agonist engagement is needed to saturate the receptor Cardiac research: Preclinical evidence for GHSR-1a-mediated cardioprotective effects potentially through PI3K/Akt survival signaling in cardiomyocytes, independent of GH elevation GHRP-6: The Original Ghrelin Mimetic GHRP-6 is the compound that started all of this
Because both compounds work upstream at the pituitary, your body retains its own feedback control
DNA Repair & Epigenetic Modulation: Upregulates genes associated with tissue repair, youthfulness, and cellular longevity
Favorable Profile for Endocrine Pharmacology Studies Ipamorelins short-acting, receptor-specific design allows precise timing and dose control, which is ideal for pharmacokinetic and pharmacodynamic research involving peptidereceptor interactions
Clinical observations report that subcutaneous dosing 3060 minutes before bedtime shortens sleep latency and increases deepsleep proportion within 12 weeks, with optimal benefits after 68 weeks of therapy Peptide therapy improves sleep by restoring natural hormone production
